Troy Hamilton

No open positions remaining

54 year

Health Technology

Consumer Services

Profile

Troy Hamilton formerly worked at Synergy Pharmaceuticals LLC, as Chief Executive Officer & Director from 2017 to 2019, Ellodi Pharmaceuticals, as Chief Executive Officer & Director from 2020 to 2024, and Shire Pharmaceuticals, Inc., as Vice President-Product Strategy.
Mr. Hamilton received his Masters Business Admin degree from St. Joseph's University and undergraduate degree from the University of the Sciences in Philadelphia.

Former positions of Troy Hamilton

Companies	Position	End
Ellodi Pharmaceuticals Ellodi Pharmaceuticals BiotechnologyHealth Technology Develops novel therapy for the treatment of eosinophilic esophagitis	Chief Executive Officer	2024-10-31
SYNERGY PHARMACEUTICALS INC	Chief Executive Officer	2019-04-30
Shire Pharmaceuticals, Inc. Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Corporate Officer/Principal	-

See the detail of Troy Hamilton's experience

Training of Troy Hamilton

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Troy Hamilton's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
St. Joseph's University St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of the Sciences in Philadelphia University of the Sciences in Philadelphia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Shire Pharmaceuticals, Inc. Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Synergy Pharmaceuticals LLC Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases	Health Technology
Ellodi Pharmaceuticals Ellodi Pharmaceuticals BiotechnologyHealth Technology Develops novel therapy for the treatment of eosinophilic esophagitis	Health Technology